PBH

Prestige Brand Holdings Inc

PBH, USA

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

https://www.prestigebrands.com

Stock Price

$0.00

0%

increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
PBH
stock
PBH

Why PBH stock stays undervalued - Bond Market & Weekly Setup with High ROI Potential bollywoodhelpline.com

Read more →
PBH
stock
PBH

(PBH) Risk-Controlled Trading Report (PBH:CA) Stock Traders Daily

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$78

Analyst Picks

Strong Buy

3

Buy

0

Hold

3

Sell

1

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Very High

15.16

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Low

1.76

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

2.31 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

1.23 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

20.20 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

0.89

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 105.46% of the total shares of Prestige Brand Holdings Inc

1.

BlackRock Inc

(16.1884%)

since

2025/06/30

2.

Vanguard Group Inc

(11.4459%)

since

2025/06/30

3.

iShares Core S&P Small-Cap ETF

(5.971%)

since

2025/08/31

4.

Dimensional Fund Advisors, Inc.

(5.0235%)

since

2025/06/30

5.

Ariel Investments, LLC

(4.475%)

since

2025/06/30

6.

State Street Corp

(4.0629%)

since

2025/06/30

7.

Macquarie Group Ltd

(3.9973%)

since

2025/06/30

9.

Vanguard Total Stock Mkt Idx Inv

(3.1761%)

since

2025/07/31

10.

Allspring Global Investments Holdings, LLC

(3.0926%)

since

2025/06/30

11.

Geode Capital Management, LLC

(2.8712%)

since

2025/06/30

12.

Amvescap Plc.

(2.5902%)

since

2025/06/30

13.

Vanguard Small Cap Index

(2.4386%)

since

2025/07/31

14.

iShares Russell 2000 ETF

(2.4181%)

since

2025/08/31

15.

Morgan Stanley - Brokerage Accounts

(2.1744%)

since

2025/06/30

16.

Goldman Sachs Group Inc

(2.1423%)

since

2025/06/30

17.

Macquarie Small Cap Core I

(2.1298%)

since

2025/07/31

18.

Allspring Special Small Cap Value A

(2.0659%)

since

2025/07/31

19.

Congress Asset Management Company, LLP

(2.0514%)

since

2025/06/30

20.

Westwood Holdings Group Inc

(1.792%)

since

2025/06/30

21.

Ariel Fund Investor

(1.7074%)

since

2025/06/30

22.

BTIM Corp

(1.6259%)

since

2025/06/30

23.

Vanguard Small Cap Value Index Inv

(1.5701%)

since

2025/07/31

24.

FMR Inc

(1.5145%)

since

2025/06/30

25.

Northern Trust Corp

(1.5035%)

since

2025/06/30

26.

Bank of America Corp

(1.4658%)

since

2025/06/30

27.

Charles Schwab Investment Management Inc

(1.4388%)

since

2025/06/30

28.

Massachusetts Financial Services Company

(1.2851%)

since

2025/06/30

29.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0776%)

since

2025/07/31

30.

Fidelity Small Cap Index

(1.0078%)

since

2025/06/30

32.

DFA US Small Cap Value I

(0.8766%)

since

2025/07/31

33.

Congress Small Cap Growth Institutional

(0.8331%)

since

2025/07/31

34.

MFS New Discovery Value I

(0.8094%)

since

2025/07/31

35.

iShares Russell 2000 Value ETF

(0.7245%)

since

2025/08/31

36.

Macquarie Small Cap Value A

(0.7129%)

since

2025/07/31

37.

T. Rowe Price Integrated US Sm Gr Eq

(0.7008%)

since

2025/07/31

38.

T. Rowe Price Integrated US SmCapGrEq

(0.7008%)

since

2025/06/30

39.

Vanguard Tax-Managed Small Cap Adm

(0.6809%)

since

2025/07/31

40.

Virtus KAR Small-Cap Value I

(0.6732%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

1.16

Latest Release

Date

2025-09-30

EPS Actual

0.86

EPS Estimate

0.97

EPS Difference

-0.11

Surprise Percent

-11.3402%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4.5)
Defensive
Highly Defensive(7.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(8.3)
GARP
Fair GARP(4)
Growth
Moderate Growth(3.5)
Momentum
Strong Momentum(6.5)
Net Net
Not Undervalued (Net-Net)(2.5)
Quality
High Quality(7.5)
Value
Undervalued(6.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.